NCT00282217View on ClinicalTrials.gov

Study Evaluating Sirolimus in the Treatment of Kidney Transplant

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2006

Conditions
Kidney FailureKidney Diseases
Interventions
DRUG

Sirolimus

Trial Locations (13)

2006

Albacete

8035

Barcelona

8701

L'Hospitalet de Llobregat

11009

Cadiz

15006

A Coruña

18014

Granada

28034

Madrid

28035

Madrid

28040

Madrid

29010

Málaga

33006

Oviedo

41013

Seville

50009

Zaragoza

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00282217 - Study Evaluating Sirolimus in the Treatment of Kidney Transplant | Biotech Hunter | Biotech Hunter